We are also proud of our outstanding education and training of undergraduates, postgraduates and postdoctoral researchers, which has enabled them to establish careers in the academic world and the government and private sectors. Our engagement is strong with alumni, industry, schools, and the national and international academic community.
Our offering – Molecular Clamp enabled Universal Influenza Vaccine
Researchers from The University of Queensland’s School of Chemistry and Molecular Biosciences have developed a novel vaccine that can provide protection against broad strains of influenza, up to 80 times more effectively than current commercial options.
It does this by ‘clamping’ key structural elements to expose highly immunogenic epitopes and therefore generate a strong host immune response.
Called ‘Molecular Clamp’, it has the potential to drive the development of a new generation of vaccines. The strategy is to advance its influenza vaccine through an industry-designed ferret model (non-diluting funding already secured) to demonstrate broad-spectrum, cross-seasonal coverage and, hence, a universal influenza vaccine.
Earlier stage programs include Respiratory Syncytial Virus and MERS vaccines, and may be developed subject to further market validation.
We are seeking a founding investment round with tranches to advance the Molecular Clamp enabled Universal Influenza Vaccine into clinical development.